GSK 163929
CAS No. 716354-04-0
GSK 163929( GSK163929 | GSK-163929 )
Catalog No. M15738 CAS No. 716354-04-0
A potent, selective CCR5 antagonist and HIV-1 entry inhibitor with pIC50 of 8.37 and 8.46 in HOS and PBL assays, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK 163929
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective CCR5 antagonist and HIV-1 entry inhibitor with pIC50 of 8.37 and 8.46 in HOS and PBL assays, respectively.
-
DescriptionA potent, selective CCR5 antagonist and HIV-1 entry inhibitor with pIC50 of 8.37 and 8.46 in HOS and PBL assays, respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK163929 | GSK-163929
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number716354-04-0
-
Formula Weight696.255
-
Molecular FormulaC36H40ClF2N5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name4-chloro-2-fluoro-5-(4-(3-fluorophenyl)-4-(2-((1R,3r,5S)-3-(2-methyl-1H-benzo[d]imidazol-1-yl)-8-azabicyclo[3.2.1]octan-8-yl)ethyl)piperidine-1-carbonyl)-N-methylbenzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kazmierski WM, et al. J Med Chem. 2011 Jun 9;54(11):3756-67.
molnova catalog
related products
-
JMS-17-2
JMS-17-2 is a potent and selective antagonist of CX3CR1 with IC50 of 0.32 nM.
-
Plerixafor
Plerixafor (JM-3100, AMD-3100, SID-791) is a potent, selective CXCR4 inhibitor.
-
BMS-22
A potent, selective, allosteric CCR2 antagonist with binding IC50 of 5.1 nM.
Cart
sales@molnova.com